InterVenn
is a California-based AI glycoproteomics platform that offers solutions such as biomarker research and liquid biopsy assay development for the healthcare industry... Read moreInterVenn
is a California-based AI glycoproteomics platform that offers solutions such as biomarker research and liquid biopsy assay development for the healthcare industry... Read more
News
Oct 13, 2023
Business Wire
Press Release: InterVenn : InterVenn Biosciences Announces the Publication of Early Detection of Advanced Adenoma and Colorectal Cancer in Gastroenterology, the Flagship Journal of the American Gastroenterological Association
Jun 20, 2023
The Real Deal
InterVenn: InterVenn scrubs lease for offices and labs in South SF
Jun 16, 2023
The Business Journals: San Francisco Business Times
InterVenn: Peninsula biotech InterVenn terminates South San Francisco lease amid flooded life sciences market
May 08, 2023
StreetInsider
Press Release: InterVenn : InterVenn Demonstrates Power of Its GlycoVision Platform In Advanced Adenoma and Colorectal Cancer
Apr 19, 2023
StreetInsider
Press Release: InterVenn : InterVenn Biosciences to Present Clinical Data on Circulating Serum Glycoproteins for Unprecedented Pre-Cancer Detection as "Poster of Distinction" at Digestive Disease Week 2023
Jan 05, 2023
Benzinga
InterVenn: InterVenn Biosciences Enters Next Stage with Senior Management Team Updates Focused on Commercialization
Jan 03, 2023
Yahoo
InterVenn: InterVenn Biosciences to Present at the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023
Nov 09, 2022
Acrofan
InterVenn: InterVenn Biosciences to Participate in Canaccord Genuity's MedTech, Diagnostics and Digital Health & Services Forum
Oct 06, 2022
Citybizlist
InterVenn: InterVenn Biosciences Co-Founder Carolyn Bertozzi Awarded Nobel Prize in Chemistry
Sep 06, 2022
Business Wire
Press Release: InterVenn : InterVenn Biosciences to Present at the 20th Annual Morgan Stanley Global Healthcare Conference
